Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease
Clinical trial NCT01584440 · COMPLETED
Trial details
- NCT number
- NCT01584440
- Sponsor
- Avanir Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-13
- Primary completion
- 2014-07-30
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.